Evidence map›Paper›PMID 34351992›Full record

ArticlePloS one2021

EEG p-adic quantum potential accurately identifies depression, schizophrenia and cognitive decline.

Oded Shor, Amir Glik, Amit Yaniv-Rosenfeld, Avi Valevski, Abraham Weizman, Andrei Khrennikov, Felix Benninger

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Mathematical proof of the Fisher-EscolàComputational and structural biotechnology journal · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oded ShorFelsenstein Medical Research Center, Petach Tikva, Israel.
Amir GlikSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0002-1642-3994
Amit Yaniv-RosenfeldSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Avi ValevskiSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abraham WeizmanFelsenstein Medical Research Center, Petach Tikva, Israel.ORCID 0000-0002-9765-8938
Andrei KhrennikovFaculty of Technology, Department of Mathematics Linnaeus University, Växjö, Sweden.
Felix BenningerFelsenstein Medical Research Center, Petach Tikva, Israel.ORCID 0000-0003-3097-4693

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

No diagnostic or predictive instruments to help with early diagnosis and timely therapeutic intervention are available as yet for most neuro-psychiatric disorders. A quantum potential mean and variability score (qpmvs), to identify neuropsychiatric and neurocognitive disorders with high accuracy, based on routine EEG recordings, was developed. Information processing in the brain is assumed to involve integration of neuronal activity in various areas of the brain. Thus, the presumed quantum-like structure allows quantification of connectivity as a function of space and time (locality) as well as of instantaneous quantum-like effects in information space (non-locality). EEG signals reflect the holistic (nonseparable) function of the brain, including the highly ordered hierarchy of the brain, expressed by the quantum potential according to Bohmian mechanics, combined with dendrogram representation of data and p-adic numbers. Participants consisted of 230 participants including 28 with major depression, 42 with schizophrenia, 65 with cognitive impairment, and 95 controls. Routine EEG recordings were used for the calculation of qpmvs based on ultrametric analyses, closely coupled with p-adic numbers and quantum theory. Based on area under the curve, high accuracy was obtained in separating healthy controls from those diagnosed with schizophrenia (p<0.0001), depression (p<0.0001), Alzheimer's disease (AD; p<0.0001), and mild cognitive impairment (MCI; p<0.0001) as well as in differentiating participants with schizophrenia from those with depression (p<0.0001), AD (p<0.0001) or MCI (p<0.0001) and in differentiating people with depression from those with AD (p<0.0001) or MCI (p<0.0001). The novel EEG analytic algorithm (qpmvs) seems to be a useful and sufficiently accurate tool for diagnosis of neuropsychiatric and neurocognitive diseases and may be able to predict disease course and response to treatment.

Indexed as

Quantum TheoryAdultAgedAged, 80 and overCase-Control StudiesCognitive DysfunctionDepressionEarly DiagnosisElectroencephalographyFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisRetrospective Studies

Identifiers

PMID34351992
PMCPMC8341571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.